Wed, Aug 19 06:48 PM

mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

Ars Technica•Wed, Aug 19, 2026, 04:53 PM•2 min read

The vaccine reportedly thwarted the cancer's return and spread.

Source: [Ars Technica](https://arstechnica.com/health/2026/08/mrna-cancer-vaccine-succeeded-in-phase-3-melanoma-trial-moderna-and-merck-say/)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

More Headlines

HealthABC News• 11m ago

Trump nominated Overton to be the next commissioner of the Food and Drug Administration.

FinanceInvesting.com• 21m ago

Developing story — details emerging. Check the source link for the latest updates.

HealthHacker News• 35m ago

4 points, 0 comments on Hacker News

FinanceSeeking Alpha• 39m ago

Developing story — details emerging. Check the source link for the latest updates.

WorldBBC UK• 46m ago

The Old Bailey jury is discharged after 37 hours of deliberations, after reaching one guilty verdict.

FinanceCNBC• 1h ago

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.